Stocks traded mostly to the downside Thursday with shares of companies in the tech sector leading declines as Meta Platforms and Microsoft fell following the release of their quarterly earnings.These stocks were moving Thursday:Meta Platforms missed analysts’ third-quarter earnings expectations and the stock declined 10%.

The restaurant chain posted a drop in net income and quarterly revenue missed forecasts. Chipotle said economic strains were [turning customers away from its stores](

A bidding war between Novo Nordisk and Pfizer has broken into the open for Metsera, which focuses on developing drugs to treat obesity

Pfizer Inc. (NYSE: PFE) is aware of the reckless and unprecedented proposal by Novo Nordisk A/S (NYSE: NVO) to acquire Metsera, Inc. (NASDAQ: MTSR). It is an attempt by a company with a dominant market position to suppress competition in violation of law by taking over an emerging American challenger.

With U.S. stock markets set to open in two hours, Guardant Health Inc. (GH) was up 26.2% in pre-market trading, and Metsera Inc. (MTSR) was up 19.3%.

Metsera, Inc. (($MTSR)) announced an update on their ongoing clinical study. Study Overview: Metsera, Inc. (MTSR) is conducting a Phase 1 study

Metsera (MTSR) shares have caught investor attention following a steady uptick in performance over the past 3 months. The stock has returned nearly 48% over that period, which has sparked fresh conversations about its growth trajectory.